| 摘要 |
There is provided a combination product comprising; (A) melagatran or a pharmaceutically acceptable derivative thereof; and (B) dexamethasone or a pharmaceutically acceptable derivative thereof,wherein each of components (A ) and (B) is formulated in admixture with a pharmaceutically-acceptable adjuvant, diluent or carrier, as well as the use of such a combination produ ct in the treatment of conditions including disseminated intravascular coagulation.
|
